About MS
Source Independent Living: For anybody who is about to purchase equipment to help them manage with a disability, don’t forget about VAT exemption. Here are the rules regarding VAT exemption for disabled people. Find out when you can buy mobility products and daily living aids without VAT, and how to go about it. And most importantly, don’t […]
VAT Exemption on Disability Living Products Read More »
Source Independent Living: Here are some ideas about ways that you may be able to save money on essentials if you have a disability, are elderly, and receive certain benefits, and/or have a low income.
Tips to save money – Independent Living Read More »
Source MS Trust: The MS Trust has praised the pioneering work of the MS Risk Sharing Scheme (RSS) as the final results from the scheme are published in the BMJ today (September 24).
Final results from the MS Risk Sharing Scheme (RSS) published Read More »
Source MS Society: Our new evidence review shows the link between smoking and MS is clearer than ever.
Link between smoking and MS clearer than ever Read More »
Source BBC: The over-65s vaccine will protect against three strains of flu, but people under 65, in the so-called at-risk groups, will be offered a vaccine that protects against four types of flu. At-risk groups include pregnant women and those with long-term health conditions.
Enhanced flu jab to save ‘hundreds of lives’ Read More »
Source the Telegraph: “As doctors, we are left feeling powerless when we deliver the devastating diagnosis of PPMS to people because we know there is currently no disease-modifying treatment available to help them. “It is even more frustrating that an effective treatment that can help slow the disease has been developed and made available across
MS patients denied drug which could keep them out of wheelchair Read More »
Source MS Society: Ocrelizumab should be available on the NHS for everyone with primary progressive MS who could benefit. We call on NHS England, the National Institute of Health and Care Excellence (NICE) and Roche to work together to secure a deal to make that happen.
People with primary progressive MS need ocrelizumab now Read More »
Source UAB News: Results from a clinical trial of more than 250 participants with progressive multiple sclerosis revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study also showed that the main side effects of ibudilast were gastrointestinal and headaches. The study was supported by the National Institute of Neurological Disorders and
Study shows that drug slows brain shrinkage in multiple sclerosis Read More »
Source MS Trust: Want to know more about how what you eat can affect your MS? We put some of your questions to Dr Conor Kerley, a registered dietitian who was diagnosed with MS at 16.
Want to know more about how what you eat can affect your MS? Read More »
Source Multiple Sclerosis News Today: Physical exercise fights fatigue and depression in patients with multiple sclerosis (MS), a new study reveals.
